Case Studies in Neuroscience: Lack of inhibitory synaptic plasticity in the substantia nigra pars reticulata of a patient with lithium-induced tremor.
basal ganglia
bipolar affective disorder
drug-induced tremor
lithium
synaptic plasticity
Journal
Journal of neurophysiology
ISSN: 1522-1598
Titre abrégé: J Neurophysiol
Pays: United States
ID NLM: 0375404
Informations de publication
Date de publication:
01 10 2019
01 10 2019
Historique:
pubmed:
15
8
2019
medline:
2
7
2020
entrez:
15
8
2019
Statut:
ppublish
Résumé
Tremor is a well-known side effect from many psychiatric medications, including lithium and dopamine antagonists. In patients whose psychiatric symptoms are stabilized and only respond to certain medications, deep brain stimulation may offer relief of the consequent motor complications. We report the case of an elderly male with disabling tremor related to lithium therapy for bipolar affective disorder, who was subsequently treated with deep brain stimulation. In this patient, we obtained recordings from the substantia nigra pars reticulata and performed a high-frequency stimulation protocol that robustly elicits long-term potentiation (LTP)-like changes in patients with Parkinson's disease. We hypothesized that in this patient, who did not have Parkinson's disease, the levels of inhibitory plasticity would be much greater. However, we found an unanticipated lack of plasticity in the patient with lithium-induced tremor, compared with two de novo control patients with Parkinson's disease. This patient was successfully treated with deep brain stimulation in the vicinity of the ventral oral posterior nucleus, an area of the thalamus that receives inputs from the basal ganglia. We postulate that the lithium-induced blockade of LTP may bring about motor complications such as tremor while simultaneously contributing to the therapeutic mechanism for treating the symptoms of psychiatric disorders such as bipolar affective disorder.
Identifiants
pubmed: 31411948
doi: 10.1152/jn.00203.2019
pmc: PMC6843100
doi:
Substances chimiques
Lithium
9FN79X2M3F
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1367-1372Références
Trends Neurosci. 1989 Oct;12(10):366-75
pubmed: 2479133
Bipolar Disord. 1999 Dec;1(2):87-90
pubmed: 11252664
Lancet. 1991 Feb 16;337(8738):403-6
pubmed: 1671433
N Engl J Med. 1999 May 13;340(19):1476-80
pubmed: 10320386
J Biol Chem. 2006 Dec 29;281(52):40154-63
pubmed: 17074764
J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):921-3
pubmed: 15146017
Neurobiol Dis. 2019 Apr;124:46-56
pubmed: 30391540
Neuron. 1997 Oct;19(4):893-901
pubmed: 9354335
Basic Clin Pharmacol Toxicol. 2009 Aug;105(2):113-9
pubmed: 19486334
Science. 2009 Mar 13;323(5920):1496-9
pubmed: 19286561
Neuron. 1993 May;10(5):955-62
pubmed: 8494646
Mov Disord. 2010 Jul 30;25(10):1350-6
pubmed: 20544817
Lancet Neurol. 2005 Dec;4(12):866-76
pubmed: 16297844
Mol Psychiatry. 1997 Sep;2(5):407-12
pubmed: 9322236
J Neurosci. 2004 Sep 22;24(38):8214-22
pubmed: 15385604
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8455-9
pubmed: 8710892
Exp Neurol. 2014 Nov;261:782-90
pubmed: 25205228
Cell. 1989 Nov 3;59(3):411-9
pubmed: 2553271
Trends Neurosci. 1990 Jul;13(7):281-5
pubmed: 1695404
Elife. 2017 Jun 16;6:
pubmed: 28621662
Mol Psychiatry. 2002;7 Suppl 1:S29-34
pubmed: 11986993
Eur J Neurosci. 2011 Jan;33(1):95-109
pubmed: 21073550
Trends Neurosci. 2007 May;30(5):228-35
pubmed: 17408758
Mol Neurobiol. 2005 Oct;32(2):173-202
pubmed: 16215281
Neurosci Lett. 2012 Aug 22;524(1):5-9
pubmed: 22750162
Bipolar Disord. 2009 Jun;11 Suppl 2:92-109
pubmed: 19538689
Br J Psychiatry. 1980 Feb;136:191-4
pubmed: 7370485
Parkinsonism Relat Disord. 2015 Nov;21(11):1369-70
pubmed: 26350120
Parkinsonism Relat Disord. 2008;14(3):253-6
pubmed: 17561432
Sci Rep. 2017 Sep 14;7(1):11609
pubmed: 28912551
CNS Drugs. 2013 Feb;27(2):135-53
pubmed: 23371914
Neuropsychopharmacology. 2008 Jan;33(1):110-33
pubmed: 17912251
Curr Biol. 2018 May 7;28(9):1333-1343.e4
pubmed: 29657115
J Neurochem. 2003 May;85(4):872-81
pubmed: 12716419
Trends Neurosci. 1990 Jul;13(7):266-71
pubmed: 1695401
Brain. 2009 Feb;132(Pt 2):309-18
pubmed: 19050033
Front Neurol. 2018 May 25;9:341
pubmed: 29887826
J Neurosci. 1996 Apr 1;16(7):2365-72
pubmed: 8601816
Mov Disord. 2011 May;26(6):1096-105
pubmed: 21626554
Ann Neurol. 1998 Oct;44(4):622-8
pubmed: 9778260
Mov Disord. 2001 Sep;16(5):867-75
pubmed: 11746616
Brain. 2018 Jul 1;141(7):2142-2155
pubmed: 29878147
Biochem J. 1992 Mar 1;282 ( Pt 2):377-85
pubmed: 1546953
Brain Res Brain Res Rev. 1995 Jan;20(1):128-54
pubmed: 7711765
Brain. 2018 Jan 1;141(1):177-190
pubmed: 29236966
Trends Neurosci. 2007 May;30(5):211-9
pubmed: 17367873
Brain Res. 2014 Jan 13;1542:79-84
pubmed: 24161826
Mol Psychiatry. 2003 Aug;8(8):721-37, 715
pubmed: 12888801
J Neurophysiol. 2005 Aug;94(2):1104-14
pubmed: 16061489
Neurosci Lett. 1990 Aug 14;116(1-2):136-40
pubmed: 2147981
J Neurochem. 1992 Dec;59(6):2332-5
pubmed: 1431911
J Psychosom Res. 2002 Aug;53(2):647-54
pubmed: 12169339
J Comp Neurol. 1991 Dec 8;314(2):319-49
pubmed: 1723998
Biol Psychiatry. 2000 Oct 15;48(8):740-54
pubmed: 11063971
Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8358-62
pubmed: 8078888
Biol Psychiatry. 2006 Jun 15;59(12):1160-71
pubmed: 16457783
Prog Brain Res. 1990;85:119-46
pubmed: 2094891
J Anat. 2000 May;196 ( Pt 4):527-42
pubmed: 10923985